NCT00847535

An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells as Therapy for Stress Urinary Incontinence

Muscle Cell Mediated Therapy for Stress Urinary Incontinence: An Investigation of the Safety of 4 Different Doses of Autologous Muscle Derived Cells.

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 66 (actual)
• Sponsor: Cook MyoSite · Industry
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a clinical investigation approved by US FDA and Canadian Health Authority to study the safety and potential effectiveness of the autologous muscle cells for the treatment of stress urinary incontinence.

Conditions

• Stress Urinary Incontinence
• Cell Therapy

Interventions

Type	Name	Description
BIOLOGICAL	autologous muscle cell injection	Injection of autologous muscle cells

Timeline

• Start date: 2008-10-09
• Primary completion: 2011-11-02
• Completion: 2011-11-02
• First posted: 2009-02-19
• Last updated: 2023-09-08
• Results posted: 2014-01-01

Locations

3 sites across 2 countries: United States, Canada